NRx Pharmaceuticals (NRXP) Competitors $2.97 -0.01 (-0.34%) Closing price 09/19/2025 04:00 PM EasternExtended Trading$2.92 -0.05 (-1.65%) As of 09/19/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRXP vs. CRGX, RAPT, TIL, TRDA, SLS, HRTX, IMRX, GNFT, TLSA, and EPRXShould you be buying NRx Pharmaceuticals stock or one of its competitors? The main competitors of NRx Pharmaceuticals include CARGO Therapeutics (CRGX), Rapt Therapeutics (RAPT), Instil Bio (TIL), Entrada Therapeutics (TRDA), SELLAS Life Sciences Group (SLS), Heron Therapeutics (HRTX), Immuneering (IMRX), GENFIT (GNFT), Tiziana Life Sciences (TLSA), and Eupraxia Pharmaceuticals (EPRX). These companies are all part of the "pharmaceutical products" industry. NRx Pharmaceuticals vs. Its Competitors CARGO Therapeutics Rapt Therapeutics Instil Bio Entrada Therapeutics SELLAS Life Sciences Group Heron Therapeutics Immuneering GENFIT Tiziana Life Sciences Eupraxia Pharmaceuticals CARGO Therapeutics (NASDAQ:CRGX) and NRx Pharmaceuticals (NASDAQ:NRXP) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, valuation, profitability, analyst recommendations and media sentiment. Does the media favor CRGX or NRXP? In the previous week, CARGO Therapeutics and CARGO Therapeutics both had 1 articles in the media. NRx Pharmaceuticals' average media sentiment score of 1.01 beat CARGO Therapeutics' score of 0.00 indicating that NRx Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CARGO Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NRx Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has better earnings & valuation, CRGX or NRXP? NRx Pharmaceuticals is trading at a lower price-to-earnings ratio than CARGO Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCARGO TherapeuticsN/AN/A-$167.50M-$4.64-0.96NRx PharmaceuticalsN/AN/A-$25.13M-$2.24-1.33 Do analysts prefer CRGX or NRXP? CARGO Therapeutics presently has a consensus target price of $15.40, indicating a potential upside of 244.52%. NRx Pharmaceuticals has a consensus target price of $34.50, indicating a potential upside of 1,061.62%. Given NRx Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe NRx Pharmaceuticals is more favorable than CARGO Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CARGO Therapeutics 1 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.86NRx Pharmaceuticals 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is CRGX or NRXP more profitable? NRx Pharmaceuticals' return on equity of 0.00% beat CARGO Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets CARGO TherapeuticsN/A -43.21% -37.26% NRx Pharmaceuticals N/A N/A -550.94% Do institutionals & insiders have more ownership in CRGX or NRXP? 93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 4.3% of NRx Pharmaceuticals shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by insiders. Comparatively, 19.0% of NRx Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more risk & volatility, CRGX or NRXP? CARGO Therapeutics has a beta of 0.3, suggesting that its share price is 70% less volatile than the S&P 500. Comparatively, NRx Pharmaceuticals has a beta of 1.63, suggesting that its share price is 63% more volatile than the S&P 500. SummaryNRx Pharmaceuticals beats CARGO Therapeutics on 10 of the 13 factors compared between the two stocks. Get NRx Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for NRXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NRXP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRXP vs. The Competition Export to ExcelMetricNRx PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$58.84M$2.58B$5.79B$10.40BDividend YieldN/A55.37%5.63%4.60%P/E Ratio-1.3323.0280.4326.78Price / SalesN/A688.24534.22123.54Price / CashN/A175.2537.9961.55Price / Book-2.015.3515.776.40Net Income-$25.13M$32.95M$3.30B$271.80M7 Day Performance6.07%0.90%5.37%3.48%1 Month Performance13.36%5.76%8.10%9.89%1 Year Performance82.21%-3.43%81.36%28.43% NRx Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRXPNRx Pharmaceuticals3.1752 of 5 stars$2.97-0.3%$34.50+1,061.6%+81.1%$58.84MN/A-1.332Positive NewsCRGXCARGO Therapeutics1.5838 of 5 stars$4.47flat$15.40+244.5%N/A$216.17MN/A-0.96116RAPTRapt Therapeutics3.7615 of 5 stars$13.28+2.7%$21.57+62.4%+28.6%$213.83M$1.53M-0.9480Positive NewsTILInstil Bio2.6143 of 5 stars$25.77-18.2%$119.00+361.8%-66.1%$212.65MN/A-1.99410High Trading VolumeTRDAEntrada Therapeutics1.8935 of 5 stars$5.28-0.2%$25.67+386.1%-63.9%$201.22M$210.78M-2.97110SLSSELLAS Life Sciences Group1.1491 of 5 stars$1.90-0.5%$7.00+268.4%+33.6%$201.12M$1M-5.9410HRTXHeron Therapeutics3.681 of 5 stars$1.30-0.8%$4.50+246.2%-39.1%$200.81M$144.29M-65.00300IMRXImmuneering3.4017 of 5 stars$5.95+8.0%$13.00+118.5%+282.6%$200.12M$320K-3.1560GNFTGENFIT1.237 of 5 stars$3.96+0.5%$9.00+127.3%+3.3%$197.01M$76.77M0.00120News CoverageUpcoming EarningsTLSATiziana Life Sciences0.895 of 5 stars$1.62-2.4%N/A+64.5%$193.97MN/A0.008News CoverageShort Interest ↑Gap UpEPRXEupraxia Pharmaceuticals2.2429 of 5 stars$5.27-2.2%$11.00+108.7%+112.9%$193.82MN/A-6.2029 Related Companies and Tools Related Companies CARGO Therapeutics Alternatives Rapt Therapeutics Alternatives Instil Bio Alternatives Entrada Therapeutics Alternatives SELLAS Life Sciences Group Alternatives Heron Therapeutics Alternatives Immuneering Alternatives GENFIT Alternatives Tiziana Life Sciences Alternatives Eupraxia Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NRXP) was last updated on 9/20/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NRx Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NRx Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NRXP Stock Alerts